Identification of food-derived bioactive peptides in blood and other biological samples.
Recent studies have demonstrated the presence of food-derived peptides in human blood after ingestion of enzymatic hydrolysates of food proteins, while most peptides in food are degraded into amino acids during digestion and absorption. To capture and clarify the food-derived peptides in blood, solid-phase extraction (SPE) using a mini-spin...

MaxCyte is a Featured Speaker at 2nd International Stem Cells and Regenerative Medicine 2007.
'Engineering Cells for Clinical Regenerative Applications: A Practical Approach' GAITHERSBURG, Md., Jan. 16 /PRNewswire/ -- MaxCyte, Inc., a clinical stage therapeutic company and pioneer in non-viral cell loading systems, announces Joseph Fratantoni, M.D. will be a featured speaker at the 2nd International Stem Cells and Regenerative Medicine...

Arriva Pharmaceuticals Gets Protein Production Patent.
HEALTH AND BEAUTY CLOSE-UP-7 October 2008-Arriva Pharmaceuticals Gets Protein Production Patent(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Arriva Pharmaceuticals, a biopharmaceutical company focused on developing anti-inflammatory therapies, announced that it had been granted a patent in the U.S. for methods to produce certain proteins in yeast. Among...

Emergent BioSolutions Lands $24 Million Development Contract from HHS.
HEALTH AND BEAUTY CLOSE-UP-8 September 2008-Emergent BioSolutions Lands $24 Million Development Contract from HHS(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Emergent BioSolutions announced that it has received a contract from the Department of Health and Human Services (HHS) for over $24.3 million to fund the further development of Emergent's...

India to produce clotting protein.
Byline: Kounteya Sinha NEW DELHI: India will soon produce and provide the blood clotting proteins F8 and F9 free of cost to patients suffering from the world's oldest known hereditary bleeding disorder - haemophilia. The health ministry is finalising plans to set up the country's...

Clinical highlights: hemolytic uremic syndrome.
Definition Hemolytic uremic syndrome (HUS) is a clinical triad of acute renal failure (serum creatinine > 1.6 mg/dl), microangiopathic hemolytic anemia (hematocrit < 25%), and thrombocytopenia (platelet count < 100,000 cells/ml) (Lesesne et al., 1989). Pathophysiology The most common chemotherapy agent to cause...

Hemolytic uremic syndrome.
A.P., a 42-year-old woman, presented with rectal bleeding to her primary care physician. Endoscopic examination revealed a mass in the anal canal. Biopsy was positive for squamous cell carcinoma. A.P. underwent local excision and was established as stage II (T2N0M0). After surgery, she received 5-fluorouracil (FU) 1,000 mg/[m.sup.2] by...

Research and Markets Adds Report: Competitor Analysis: Antithrombotics.
HEALTH AND BEAUTY CLOSE-UP-13 August 2008-Research and Markets Adds Report: Competitor Analysis: Antithrombotics(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Research and Markets has announced the addition of the "Competitor Analysis: Antithrombotics" report to their offering. In a release, Research and Markets noted that report highlights include: ...

NovoSeven RT.
(Coagulation Factor VIIa [Recombinant], Novo Nordisk A/S) A new formulation of recombinant factor VIIa that can be stored at room temperature for up to 2 years, approved by the Food and Drug Administration in May for the same indications as NovoSeven Coagulation Factor VIIa (Recombinant): prevention of...

BAYER EXPANDS HEMOPHILIA PORTFOLIO FEATURING MAXY-VII.
Bayer HealthCare is expanding its commitment to hemophilia with the acquisition of Maxygen's hemophilia program assets, including a next-generation recombinant Factor VIIa protein known as MAXY-VII. The lead therapeutic candidate is expected to enter Phase 1 clinical testing in the third quarter of 2008. The total transaction is valued...